Literature DB >> 15815936

Cardiovascular effects of anti-G suit inflation at 1 and 2 G.

Stéphanie Montmerle1, Dag Linnarsson.   

Abstract

We sought to determine to which pressure a full-coverage anti-G suit needs to be inflated in order to obtain the same stroke volume during a brief exposure to twice the normal gravity (2 G) as that at 1 G without anti-G suit inflation. Nine sitting subjects were studied at normal (1 G) and during 20 s of exposure to 2 G. They wore anti-G suits, which were inflated at both G-levels to the following target pressures: 0, 70, 140 and 210 mmHg. Stroke volume was computed from cardiac output, which was measured by rebreathing. Heart rate and mean arterial pressure at heart level were recorded. Inflation to 70 mmHg compensated for the decrease in stroke volume and cardiac output caused by hypergravity. Mean arterial pressure at heart level was comparable at 1 G and at 2 G and increased gradually and similarly with inflation (P<0.001) at both gravity levels. Thus, anti-G suits act by increasing both preload and afterload but the two effects counteract each other in terms of cardiac output, so that cardiac output at 2 G is maintained at its 1 G level. This effect is reached already at 70 mmHg of inflation. Greater inflation pressure further increases mean arterial pressure at heart level and compensates for the increased difference in hydrostatic pressure between heart and head in moderate hypergravity.

Entities:  

Mesh:

Year:  2005        PMID: 15815936     DOI: 10.1007/s00421-005-1331-6

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  33 in total

1.  Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing.

Authors:  G Parati; R Casadei; A Groppelli; M Di Rienzo; G Mancia
Journal:  Hypertension       Date:  1989-06       Impact factor: 10.190

2.  Central venous pressure in humans during short periods of weightlessness.

Authors:  P Norsk; N Foldager; F Bonde-Petersen; B Elmann-Larsen; T S Johansen
Journal:  J Appl Physiol (1985)       Date:  1987-12

3.  Effects of an anti-G suit on the hemodynamic and renal responses to positive (+Gz) acceleration.

Authors:  S J Shubrooks; M Epstein; D C Duncan
Journal:  J Appl Physiol       Date:  1974-03       Impact factor: 3.531

4.  Rebreathing techniques for pulmonary capillary blood flow and tissue volume.

Authors:  M A Sackner; G Markwell; N Atkins; S J Birch; R J Fernandez
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-11

Review 5.  Reliability and validity of measures of cardiac output during incremental to maximal aerobic exercise. Part II: Novel techniques and new advances.

Authors:  D E Warburton; M J Haykowsky; H A Quinney; D P Humen; K K Teo
Journal:  Sports Med       Date:  1999-04       Impact factor: 11.136

6.  Telemetric animal model to evaluate visceral pain in the freely moving rat.

Authors:  M J M A Nijsen; N G H Ongenae; B Coulie; A L Meulemans
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

7.  Computerized determination of pneumotachometer characteristics using a calibrated syringe.

Authors:  M P Yeh; R M Gardner; T D Adams; F G Yanowitz
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-07

8.  Hemodynamic effects of Medical Anti-Shock Trousers (MAST garment).

Authors:  F A Gaffney; E R Thal; W F Taylor; B C Bastian; J A Weigelt; J M Atkins; C G Blomqvist
Journal:  J Trauma       Date:  1981-11

9.  A model of the effects of respiration on left ventricular performance.

Authors:  J L Robotham; W Mintzner
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-03

10.  A comparison between freon and acetylene rebreathing for measuring cardiac output.

Authors:  F Bonde-Petersen; P Norsk; Y Suzuki
Journal:  Aviat Space Environ Med       Date:  1980-11
View more
  1 in total

1.  Limitations of stroke volume estimation by non-invasive blood pressure monitoring in hypergravity.

Authors:  Olivier Manen; Caroline Dussault; Fabien Sauvet; Stéphanie Montmerle-Borgdorff
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.